16:33 EDT Aslan Pharmaceuticals files to sell 61.9M ordinary shares for holders
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASLN:
- Aslan Pharmaceuticals Amends Loan Conversion Terms
- ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
- Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
- ASLAN Pharmaceuticals Excels in Eblasakimab Trials
- Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue